Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 1: Currently Available Injectable Biologic Therapies for Moderate-to-Severe Atopic Dermatitis (AD)

Target Audience
This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis.

Program Overview
This activity features a case presentation, a brief overview of currently available injectable biologic therapies, and insights from an expert faculty.

Learning Objectives
After completing this activity, the participant should be better able to::

Identify the biologic properties and mechanisms of action of current and emerging biological therapies for moderate-to-severe atopic dermatitis
Evaluate evidence on the efficacy and safety, along with the impact on patients’ quality of life, of current and emerging biological therapies for moderate-to-severe atopic dermatitis
Apply patient-, disease-, and therapy-specific considerations in treatment decisions for patients with moderate-to-severe atopic dermatitis